MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 69 filers reported holding MEI PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $81,593 | -53.0% | 356,455 | -50.0% | 0.00% | – |
| Q4 2022 | $173,664 | +25.8% | 712,910 | +100.0% | 0.00% | – |
| Q3 2022 | $138,000 | -36.1% | 356,455 | 0.0% | 0.00% | – |
| Q2 2022 | $216,000 | -81.6% | 356,455 | -81.7% | 0.00% | – |
| Q1 2022 | $1,174,000 | -76.7% | 1,949,006 | +3.3% | 0.00% | – |
| Q4 2021 | $5,039,000 | -3.7% | 1,887,174 | -0.4% | 0.00% | – |
| Q3 2021 | $5,230,000 | -1.9% | 1,894,784 | +1.2% | 0.00% | – |
| Q2 2021 | $5,334,000 | -12.1% | 1,871,702 | +5.7% | 0.00% | – |
| Q1 2021 | $6,071,000 | +26.3% | 1,770,116 | -2.8% | 0.00% | – |
| Q4 2020 | $4,805,000 | -14.9% | 1,820,218 | +0.6% | 0.00% | – |
| Q3 2020 | $5,645,000 | -25.9% | 1,809,409 | -1.9% | 0.00% | -100.0% |
| Q2 2020 | $7,615,000 | +210.6% | 1,843,737 | +21.0% | 0.00% | – |
| Q1 2020 | $2,452,000 | -17.2% | 1,523,273 | +27.6% | 0.00% | – |
| Q4 2019 | $2,961,000 | +62.7% | 1,193,827 | +10.2% | 0.00% | – |
| Q3 2019 | $1,820,000 | -20.4% | 1,083,220 | +18.5% | 0.00% | – |
| Q2 2019 | $2,286,000 | +1997.2% | 914,210 | +2479.6% | 0.00% | – |
| Q1 2019 | $109,000 | +58.0% | 35,440 | +35.6% | 0.00% | – |
| Q4 2018 | $69,000 | -95.5% | 26,136 | -81.1% | 0.00% | – |
| Q1 2014 | $1,539,000 | +64.8% | 138,480 | +18.9% | 0.00% | – |
| Q4 2013 | $934,000 | -1.4% | 116,501 | +39.3% | 0.00% | – |
| Q3 2013 | $947,000 | +1129.9% | 83,610 | +670.8% | 0.00% | – |
| Q2 2013 | $77,000 | – | 10,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|